Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

ICRMYELOMA · Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma

FP7Status: CLOSED1 August 201231 July 2014EU funding €209,033

Plasma cell myeloma (PCM) is an incurable malignancy. Cytogenetics, molecular genetics and single nucleotide polymorphism arrays have shown significant genetic complexity in PCM. However, these screens reflect only the predominant clonal population and genetic-based prognostic classification of PCM can predict the outcome only in a subset of cases. To better understand the oncogenesis of PCM combined investigation of genetic abnormalities at single cell level is needed.The original theory of clonal evolution in cancer proposed a stepwise, linear acquisition of mutations

Consortium · 1 organisation

coordinator

INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG

UK · €209,033

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.